RecruitingNCT06506825

Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology

The Fourth Hospital of Hebei Medical University

Sponsor

Qun Zhao

Enrollment

30,000 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

The Study Focuses on Gastric Cancer

Summary

This clinical trial aims to construct and apply a collaborative network database for gastric cancer in Hebei Province, driven by artificial intelligence (AI) technology. The project seeks to integrate clinical data, genomic information, and treatment outcomes from multiple hospitals and research centers within the region. By leveraging advanced AI algorithms, the database will facilitate comprehensive data analysis to identify novel biomarkers, optimize therapeutic strategies, and improve patient outcomes. This initiative will also support real-time data sharing and collaboration among healthcare providers, researchers, and policymakers, ultimately enhancing the overall management and treatment of gastric cancer in Hebei Province.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a database-building and AI research study in Hebei Province, China, that is collecting comprehensive data on gastric cancer patients to drive research using artificial intelligence. The goal is to better understand patterns in stomach cancer treatment and outcomes across the region, ultimately improving care. **You may be eligible if...** - You have been diagnosed with gastric (stomach) cancer **You may NOT be eligible if...** - There are no specific exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTGastric Cancer AI-driven Data Integration Genomic Analysis Biomarker

Enter the clinical and related test, examination and treatment information of all gastric cancer patients, and find risk factors that affect the prognosis

Locations(1)

Department of General Surgery

Shijiazhuang, Hebei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06506825